Literature DB >> 7105055

Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.

R T Eagan, R P Dinapoli, R C Hermann, R V Groover, D D Layton, M Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105055

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  5 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group Report.

Authors:  H J Eyre; J M Quagliana; J R Eltringham; J Frank; R M O'Bryan; B McDonald; S E Rivkin
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.

Authors:  D Afra; B Kocsis; S Kerpel-Fronius; S Eckhardt
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.

Authors:  E Institóris; K Szikla; L Otvös; F Gál
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Improving vaccine efficacy against malignant glioma.

Authors:  Erik Ladomersky; Matthew Genet; Lijie Zhai; Galina Gritsina; Kristen L Lauing; Rishi R Lulla; Jason Fangusaro; Alicia Lenzen; Priya Kumthekar; Jeffrey J Raizer; David C Binder; C David James; Derek A Wainwright
Journal:  Oncoimmunology       Date:  2016-06-10       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.